These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3074744

  • 1. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
    [Abstract] [Full Text] [Related]

  • 2. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
    [Abstract] [Full Text] [Related]

  • 3. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
    [Abstract] [Full Text] [Related]

  • 4. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
    Hast R, Dowding C, Robak T, Goldman JM.
    Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
    [Abstract] [Full Text] [Related]

  • 5. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1989 Nov; 37(1-2):17-28. PubMed ID: 2619501
    [Abstract] [Full Text] [Related]

  • 6. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T, Dowding C, Garewal G, Hibbin JA, Th'ng KH, Goldman JM.
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [Abstract] [Full Text] [Related]

  • 7. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Sep; 36(6):733-47. PubMed ID: 3254121
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
    Kubota Y, Tanaka T, Irino S.
    Leuk Res; 1991 Sep; 15(4):195-204. PubMed ID: 2030600
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D, Strife A, Arlin Z, Knowles R, Lambek C, Gulati S, McHendry B, McKenzie S, Clarkson B.
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [Abstract] [Full Text] [Related]

  • 10. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T, Nolasco I, Hibbin J, Goldman JM.
    Leuk Res; 1985 Jun; 9(8):1023-9. PubMed ID: 2413317
    [Abstract] [Full Text] [Related]

  • 11. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E.
    J Immunol; 1987 Sep 15; 139(6):1823-9. PubMed ID: 3114377
    [Abstract] [Full Text] [Related]

  • 12. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M, Nagler A, Lishner M, Amiel A, Yarkoni S, Rudi A, Gellerman G, Kashman Y, Fabian I.
    Clin Cancer Res; 1995 Aug 15; 1(8):823-9. PubMed ID: 9816051
    [Abstract] [Full Text] [Related]

  • 13. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D, Tarella C, Pregno P, Pileri A, Gallo E.
    Cancer Res; 1986 Feb 15; 46(2):975-80. PubMed ID: 3455679
    [Abstract] [Full Text] [Related]

  • 14. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F, Bi S, Castoldi G, Goldman JM.
    Leukemia; 1993 Oct 15; 7(10):1570-5. PubMed ID: 7692192
    [Abstract] [Full Text] [Related]

  • 15. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu.
    Eksp Onkol; 1984 Oct 15; 6(5):53-5. PubMed ID: 6239771
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS, Wade PM, Quesenberry PJ.
    J Immunol; 1984 Dec 15; 133(6):2940-9. PubMed ID: 6149245
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
    Hirayama Y, Kohgo Y, Kanisawa Y, Fujii S, Ikeda K, Matsunaga T, Ito Y, Sakamaki S, Niitsu Y.
    Int J Hematol; 1993 Jun 15; 57(3):265-8. PubMed ID: 8364189
    [Abstract] [Full Text] [Related]

  • 20. Clinical manifestations of chronic granulocytic leukemia.
    Spiers AS.
    Semin Oncol; 1995 Aug 15; 22(4):380-95. PubMed ID: 7638635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.